Detection of amyloid fibrils in Parkinson’s disease using plasmonic chirality

Jatish Kumar, Hasier Eraña, Elena López‐Martínez, +7

Proceedings of the National Academy of Sciences

Cofactors influence the biological properties of infectious recombinant prions

Natalia Fernández‐Borges, Michele Angelo Di Bari, Hasier Eraña, +17

Acta Neuropathologica

Infectious Recombinant PrionsNatural SciencesMedicinePathogenesisVirulence Factor +4

Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria

Pedro Urquiza, Ana Laín, Arantza Sanz-Parra, +22

Science Translational Medicine

Dogs are resistant to prion infection, due to the presence of aspartic or glutamic acid at position 163 of their prion protein

Enríc Vidal, Natalia Fernández‐Borges, Hasier Eraña, +10

The FASEB Journal

Unraveling the key to the resistance of canids to prion diseases

Natalia Fernández‐Borges, Beatriz Parra, Enríc Vidal, +7

PLoS Pathogens

BiologyCreutzfeldt-jakob DiseaseMedicineGeneticsPathogenesis +13

Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies

Hasier Eraña, Jorge M. Charco, Michele Angelo Di Bari, +22

PLoS Pathogens

EngineeringCreutzfeldt-jakob DiseaseMolecular BiologyDextran SulfateProtein Folding +16

Naturally prion resistant mammals

Natalia Fernández‐Borges, Francesca Chianini, Hasier Eraña, +6

Prion

Post-translational modifications in PrP expand the conformational diversity of prions in vivo

Patricia Aguilar‐Calvo, Xiangzhu Xiao, Cyrus Bett, +6

Scientific Reports

Transgenic Mouse Bioassay: Evidence That Rabbits Are Susceptible to a Variety of Prion Isolates

Enríc Vidal, Natalia Fernández‐Borges, Belén Pintado, +10

PLoS Pathogens

Transgenic Mouse BioassayTransgenic Mouse ModelsGeneticsPathologyEducation +18

Nonpathogenic Mycobacterium brumae Inhibits Bladder Cancer Growth In Vitro, Ex Vivo, and In Vivo

Estela Noguera-Ortega, Silvia Secanella-Fandos, Hasier Eraña, +5

European Urology Focus

Ex VivoUrologyGenitourinary CancerOncogenic AgentMedicine +6